Colorectal Cancer Growth Retardation through Induction of Apoptosis, Using an Optimized Synergistic Cocktail of Axitinib, Erlotinib, and Dasatinib

Patients with advanced colorectal cancer (CRC) still depend on chemotherapy regimens that are associated with significant limitations, including resistance and toxicity. The contribution of tyrosine kinase inhibitors (TKIs) to the prolongation of survival in these patients is limited, hampering clin...

Descripción completa

Detalles Bibliográficos
Autores principales: Berndsen, Robert H., Swier, Nathalie, van Beijnum, Judy R., Nowak-Sliwinska, Patrycja
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6966484/
https://www.ncbi.nlm.nih.gov/pubmed/31783534
http://dx.doi.org/10.3390/cancers11121878

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6966484/
https://www.ncbi.nlm.nih.gov/pubmed/31783534
http://dx.doi.org/10.3390/cancers11121878

Ejemplares similares